biotechnologyAI-Designed Cancer Drug BD200 Defeats Resistant Tumors, Outperforms Marketed AntibodiesSalvado•Apr 19, 2026
Health & ScienceAI-Designed Antibody BD200 Outperforms Standard Treatments in Drug-Resistant Cancers, Marking First Clinical Trial for Machine Learning PlatformSalvado•Apr 18, 2026
